Cargando…

Evaluation of Pharmacy Model in a Trial of Free Essential Medicine Access

Background: In Canada, pharmacists accessing electronic health records (EHR) and mailing medications to patients are relatively uncommon. We evaluated a pharmacy model implemented in a clinical trial that combined allowing the pharmacist access to patients’ EHR and mailing medications to participant...

Descripción completa

Detalles Bibliográficos
Autores principales: Ally, Muhamad Z., Persaud, Nav, Umali, Norman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7252367/
https://www.ncbi.nlm.nih.gov/pubmed/32450757
http://dx.doi.org/10.1177/2150132720923938
_version_ 1783539146656055296
author Ally, Muhamad Z.
Persaud, Nav
Umali, Norman
author_facet Ally, Muhamad Z.
Persaud, Nav
Umali, Norman
author_sort Ally, Muhamad Z.
collection PubMed
description Background: In Canada, pharmacists accessing electronic health records (EHR) and mailing medications to patients are relatively uncommon. We evaluated a pharmacy model implemented in a clinical trial that combined allowing the pharmacist access to patients’ EHR and mailing medications to participants. Methods: We conducted thematic analysis of comments made by participants and prescribers, and chart stimulated recalls with the pharmacist involved with the novel pharmacy model implemented in a clinical trial. Results: Major themes from participant’s comments related to the ease of obtaining information about medications from the pharmacy and satisfaction with the delivery. Prescribers felt that this model facilitated collaboration with the pharmacist and welcomed suggestions regarding therapeutic medication changes. Major themes from the pharmacist’s chart stimulated recalls were that access to participants’ EHRs allowed for improved drug therapy management and participant experience, and this pharmacy model increased participant’s access to pharmacy services. Discussion: According to the pharmacist and prescribers, this pharmacy model facilitated their collaboration in prescribing appropriate medications and participants were generally satisfied with the delivery of medications. Conclusion: Participants and prescribers were generally supportive of a pharmacy model that combined allowing the pharmacist access to participants’ EHR and medication mailing. This allowed the pharmacist more opportunities for drug therapy management and collaboration with prescribers. It also improved the participant’s access to pharmacy services, although those services were not always fully utilized.
format Online
Article
Text
id pubmed-7252367
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-72523672020-06-08 Evaluation of Pharmacy Model in a Trial of Free Essential Medicine Access Ally, Muhamad Z. Persaud, Nav Umali, Norman J Prim Care Community Health Original Research Background: In Canada, pharmacists accessing electronic health records (EHR) and mailing medications to patients are relatively uncommon. We evaluated a pharmacy model implemented in a clinical trial that combined allowing the pharmacist access to patients’ EHR and mailing medications to participants. Methods: We conducted thematic analysis of comments made by participants and prescribers, and chart stimulated recalls with the pharmacist involved with the novel pharmacy model implemented in a clinical trial. Results: Major themes from participant’s comments related to the ease of obtaining information about medications from the pharmacy and satisfaction with the delivery. Prescribers felt that this model facilitated collaboration with the pharmacist and welcomed suggestions regarding therapeutic medication changes. Major themes from the pharmacist’s chart stimulated recalls were that access to participants’ EHRs allowed for improved drug therapy management and participant experience, and this pharmacy model increased participant’s access to pharmacy services. Discussion: According to the pharmacist and prescribers, this pharmacy model facilitated their collaboration in prescribing appropriate medications and participants were generally satisfied with the delivery of medications. Conclusion: Participants and prescribers were generally supportive of a pharmacy model that combined allowing the pharmacist access to participants’ EHR and medication mailing. This allowed the pharmacist more opportunities for drug therapy management and collaboration with prescribers. It also improved the participant’s access to pharmacy services, although those services were not always fully utilized. SAGE Publications 2020-05-26 /pmc/articles/PMC7252367/ /pubmed/32450757 http://dx.doi.org/10.1177/2150132720923938 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Research
Ally, Muhamad Z.
Persaud, Nav
Umali, Norman
Evaluation of Pharmacy Model in a Trial of Free Essential Medicine Access
title Evaluation of Pharmacy Model in a Trial of Free Essential Medicine Access
title_full Evaluation of Pharmacy Model in a Trial of Free Essential Medicine Access
title_fullStr Evaluation of Pharmacy Model in a Trial of Free Essential Medicine Access
title_full_unstemmed Evaluation of Pharmacy Model in a Trial of Free Essential Medicine Access
title_short Evaluation of Pharmacy Model in a Trial of Free Essential Medicine Access
title_sort evaluation of pharmacy model in a trial of free essential medicine access
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7252367/
https://www.ncbi.nlm.nih.gov/pubmed/32450757
http://dx.doi.org/10.1177/2150132720923938
work_keys_str_mv AT allymuhamadz evaluationofpharmacymodelinatrialoffreeessentialmedicineaccess
AT persaudnav evaluationofpharmacymodelinatrialoffreeessentialmedicineaccess
AT umalinorman evaluationofpharmacymodelinatrialoffreeessentialmedicineaccess